Literature DB >> 27519163

Quantitative proteome analysis reveals the correlation between endocytosis-associated proteins and hepatocellular carcinoma dedifferentiation.

Wael Naboulsi1, Thilo Bracht2, Dominik A Megger2, Henning Reis3, Maike Ahrens2, Michael Turewicz2, Martin Eisenacher2, Stephanie Tautges2, Ali E Canbay4, Helmut E Meyer2, Frank Weber5, Hideo A Baba3, Barbara Sitek6.   

Abstract

The majority of poorly differentiated hepatocellular carcinomas (HCCs) develop from well-differentiated tumors. Endocytosis is a cellular function which is likely to take part in this development due to its important role in regulating the abundances of vital signaling receptors. Here, we aimed to investigate the abundance of endocytosis-associated proteins in HCCs with various differentiation grades. Therefore, we analyzed 36 tissue specimens from HCC patients via LC-MS/MS-based label-free quantitative proteomics including 19 HCC tissue samples with different degrees of histological grades and corresponding non-tumorous tissue controls. As a result, 277 proteins were differentially regulated between well-differentiated tumors and controls. In moderately and poorly differentiated tumors, 278 and 1181 proteins, respectively, were significantly differentially regulated compared to non-tumorous tissue. We explored the regulated proteins based on their functions and identified thirty endocytosis-associated proteins, mostly overexpressed in poorly differentiated tumors. These included proteins that have been shown to be up-regulated in HCC like clathrin heavy chain-1 (CLTC) as well as unknown proteins, such as secretory carrier-associated membrane protein 3 (SCAMP3). The abundances of SCAMP3 and CLTC were immunohistochemically examined in tissue sections of 84 HCC patients. We demonstrate the novel association of several endocytosis-associated proteins, in particular, SCAMP3 with HCC progression.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CLTC; Endocytosis; Hepatocellular carcinoma; Label-free proteomics; Liver; SCAMP3

Mesh:

Substances:

Year:  2016        PMID: 27519163     DOI: 10.1016/j.bbapap.2016.08.005

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  11 in total

1.  Elevated expression of ISY1, APOA-1, SYNE1, MTG1, and MMP10 at HCC initiation: HCC specific protein network involving interactions of key regulators of lipid metabolism, EGFR signaling, MAPK, and splicing pathways.

Authors:  Laila H Faraj Shaglouf; Maryam Ranjpour; Saima Wajid; Rakesh Tandon; Karisangal Ramaswamy Vasudevan; Swatantra Kumar Jain
Journal:  Protoplasma       Date:  2022-08-12       Impact factor: 3.186

2.  SCAMP3 Regulates EGFR and Promotes Proliferation and Migration of Triple-Negative Breast Cancer Cells through the Modulation of AKT, ERK, and STAT3 Signaling Pathways.

Authors:  Ariana Acevedo-Díaz; Beatriz M Morales-Cabán; Astrid Zayas-Santiago; Michelle M Martínez-Montemayor; Ivette J Suárez-Arroyo
Journal:  Cancers (Basel)       Date:  2022-06-05       Impact factor: 6.575

3.  Comprehensive Evaluation of Endocytosis-Associated Protein SCAMP3 in Hepatocellular Carcinoma.

Authors:  Ao Zhou; Hongjing Liu; Bin Tang
Journal:  Pharmgenomics Pers Med       Date:  2020-10-07

4.  Overexpression of SCAMP3 is an indicator of poor prognosis in hepatocellular carcinoma.

Authors:  Xinyuan Zhang; Jie Sheng; Yuhong Zhang; Yu Tian; Jie Zhu; Nan Luo; Congshu Xiao; Rongkuan Li
Journal:  Oncotarget       Date:  2017-11-27

5.  Identification of the Consistently Altered Metabolic Targets in Human Hepatocellular Carcinoma.

Authors:  Zeribe Chike Nwosu; Dominik Andre Megger; Seddik Hammad; Barbara Sitek; Stephanie Roessler; Matthias Philip Ebert; Christoph Meyer; Steven Dooley
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2017-05-31

6.  Deciphering of the Human Interferon-Regulated Proteome by Mass Spectrometry-Based Quantitative Analysis Reveals Extent and Dynamics of Protein Induction and Repression.

Authors:  Dominik A Megger; Jos Philipp; Vu Thuy Khanh Le-Trilling; Barbara Sitek; Mirko Trilling
Journal:  Front Immunol       Date:  2017-09-14       Impact factor: 7.561

7.  SCAMP3 Promotes Glioma Proliferation and Indicates Unfavorable Prognosis via Multiple Pathways.

Authors:  Chunliu Li; Zhen Zhang; Peng Lv; Yan Zhan; Qianwei Zhong
Journal:  Onco Targets Ther       Date:  2020-05-01       Impact factor: 4.147

8.  Liver cancer cell lines distinctly mimic the metabolic gene expression pattern of the corresponding human tumours.

Authors:  Zeribe C Nwosu; Nadia Battello; Melanie Rothley; Weronika Piorońska; Barbara Sitek; Matthias P Ebert; Ute Hofmann; Jonathan Sleeman; Stefan Wölfl; Christoph Meyer; Dominik A Megger; Steven Dooley
Journal:  J Exp Clin Cancer Res       Date:  2018-09-03

9.  Regulation of the EGFR/ErbB signalling by clathrin in response to various ligands in hepatocellular carcinoma cell lines.

Authors:  Yuanhui Liu; Claire Calmel; Christèle Desbois-Mouthon; Joëlle Sobczak-Thépot; Anthi Karaiskou; Françoise Praz
Journal:  J Cell Mol Med       Date:  2020-06-09       Impact factor: 5.310

10.  Bioinformatics Analysis and RNA-Sequencing of SCAMP3 Expression and Correlated Gene Regulation in Hepatocellular Carcinoma.

Authors:  Shan-Shan Han; Zhi-Qiang Feng; Rui Liu; Jun Ye; Wei-Wei Cheng; Jun-Bo Bao
Journal:  Onco Targets Ther       Date:  2020-02-04       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.